Table 1

Baseline Characteristics

Characteristic

Calcium acetate

(N = 46)

Placebo

(N = 64)

P-value


Age (years)

63.2 ± 11.7

62.2 ± 14.2

0.69


Gender (female)

23 (50%)

29 (45.3%)

0.63


Race (white)

33 (71.7%)

54 (84.4%)

0.34


Diabetes

31 (67.4%)

49 (76.6%)

0.29


Weight (Kg)

82.9 ± 23.2

80.8 ± 25.6

0.65


Serum phosphorus (mg/dL)

5.1 ± 1.2

5.1 ± 1.1

0.76


Serum calcium, corrected (mg/dL)

9.1 ± 0.7

9.1 ± 0.6

0.97



Intact parathyroid hormone (pg/mL)1

253 ± 213

322 ± 267

0.16


Serum albumin (mg/dL)

3.6 ± 0.5

3.5 ± 0.5

0.56


Serum bicarbonate (mEq/L)

22.6 ± 3.9

21.9 ± 3.7

0.33


Estimated glomerular filtration rate (mL/min/1.73 m2)

17.3 ± 5.6

16.4 ± 6.2

0.43


1Available in 45 and 56 patients in the calcium acetate and placebo groups, respectively.

Qunibi et al. BMC Nephrology 2011 12:9   doi:10.1186/1471-2369-12-9

Open Data